Lefitolimod vs standard of care (SOC) for patients with metastatic colorectal cancer (mCRC) responding to first-line standard treatment: Results from the randomized phase III IMPALA trial

David Cunningham, Dirk Arnold, Alberto F. Sobrero et al.|Annals of Oncology|2019

Cited by 6